Erratum: Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival (Human Moleular Genetics (2009) vol. 18 (10) (1869-1878) 10.1093/hmg/ddp107);Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival

Human Molecular Genetics

Volumn 18, Issue 10, 2009, Pages 1869-1878

  Quaye, Lydia ^a   Dafou, Dimitra ^a   Ramus, Susan J ^a   Song, Honglin ^b   Maharaj, Aleksandra Gentry ^a   Notaridou, Maria ^a   Hogdall, Estrid ^c   Kjaer, Susanne Kruger ^c   Christensen, Lise ^d   Hogdall, Claus ^d   Easton, Douglas F ^b   Jacobs, Ian ^a   Menon, Usha ^a   Pharoah, Paul D P ^b   Gayther, Simon A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CASPASE 5; RETINOBLASTOMA BINDING PROTEIN 8; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE REPRESSION; GENE TRANSFER; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 65449155078     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp234     Document Type: Erratum

References (30)

1. Parkin, D.M., Bray, F., Ferlay, J. and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
2. Legge, F., Ferrandina, G., Salutari, V. and Scambia, G. (2005) Biological characterization of ovarian cancer: Prognostic and therapeutic implications. Ann. Oncol., 16 (Suppl. 4), 95-101.
3. Levi, F., Lucchini, F., Negri, E., Boyle, P. and La Vecchia, C. (2004) Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int. J. Cancer, 110, 155-169.
4. Romond, E.H., Perez, E.A., Bryant, J., Suman, V.J., Geyer, C.E. Jr., Davidson, N.E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P.A. et al. (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N. Engl. J. Med., 353, 1673-1684.
5. Piccart-Gebhart, M.J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C. et al. (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N. Engl. J. Med., 353, 1659-1672.
6. Chetrit, A., Hirsh-Yechezkel, G., Ben-David, Y., Lubin, F., Friedman, E. and Sadetzki, S. (2008) Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: The national Israeli study of ovarian cancer. J. Clin. Oncol., 26, 20-25.
7. Tan, D.S., Rothermundt, C., Thomas, K., Bancroft, E., Eeles, R., Shanley, S., Ardern-Jones, A., Norman, A., Kaye, S.B. and Gore, M.E. (2008) 'BRCAness' syndrome in ovarian cancer: A case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J. Clin. Oncol., 26, 5530-5536.
8. Quaye, L., Gayther, S.A., Ramus, S.J., Di Cioccio, R.A., McGuire, V., Hogdall, E., Hogdall, C., Blaakr, J., Easton, D.F., Ponder, B.A. et al. (2008) The effects of common genetic variants in oncogenes on ovarian cancer survival. Clin. Cancer Res., 14, 5833-5839.
9. Mann, A., Hogdall, E., Ramus, S.J., DiCioccio, R.A., Hogdall, C., Quaye, L., McGuire, V., Whittemore, A.S., Shah, M., Greenberg, D. et al. (2008) Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients. Eur. J. Cancer, 44, 2259-2265.
10. Song, H., Hogdall, E., Ramus, S.J., Dicioccio, R.A., Hogdall, C., Quaye, L., McGuire, V., Whittemore, A.S., Shah, M., Greenberg, D. et al. (2008) Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Clin. Cancer Res., 14, 1090-1095.
11. Hefler, L.A., Mustea, A., Konsgen, D., Concin, N., Tanner, B., Strick, R., Heinze, G., Grimm, C., Schuster, E., Tempfer, C. et al. (2007) Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clin. Cancer Res., 13, 898-901.
12. Pinto, D., Pereira, D., Portela, C., da Silva, J.L., Lopes, C. and Medeiros, R. (2005) The influence of HER2 genotypes as molecular markers in ovarian cancer outcome. Biochem. Biophys. Res. Commun., 335 1173-1178.
13. Cuthbert, A.P., Trott, D.A., Ekong, R.M., Jezzard, S., England, N.L., Themis, M., Todd, C.M. and Newbold, R.F. (1995) Construction and characterization of a highly stable human: Rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. Cytogenet. Cell Genet., 71, 68-76.
14. Parris, C.N., Harris, J.D., Griffin, D.K., Cuthbert, A.P., Silver, A.J. and Newbold, R.F. (1999) Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma. Cancer Res., 59, 516-520.
15. Ramus, S.J., Pharoah, P.D., Harrington, P., Pye, C., Werness, B., Bobrow, L., Ayhan, A., Wells, D., Fishman, A., Gore, M. et al. (2003) BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases. Cancer Res. 63, 417-423.
16. Wan, M., Sun, T., Vyas, R., Zheng, J., Granada, E. and Dubeau, L. (1999) Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2 cM fragment in chromosomal region 6q24-q25. Oncogene, 18, 1545-1551.
17. Reumers, J., Conde, L., Medina, I., Maurer-Stroh, S., Van Durme, J., Dopazo, J., Rousseau, F. and Schymkowitz, J. (2008) Joint annotation of coding and non-coding single nucleotide polymorphisms and mutations in the SNP effect and PupaSuite databases. Nucleic Acids Res, 36 D825-D829.
18. Thomas, D.C., Haile, R.W. and Duggan, D. (2005) Recent developments in genomewide association scans: A workshop summary and review. Am. J. Hum. Genet., 77, 337-345.
19. Lawrenson, K., Ramus, S.J. and Gayther, S.A. Somatic genetic development in epithelial ovarian cancer. In Wielsch, P. (ed.), The Role of Genetics in Breast and Reproductive Cancers, Springer (In press).
20. Fusco, C., Reymond, A. and Zervos, A.S. (1998) Molecular cloning and characterization of a novel retinoblastoma-binding protein. Genomics 51, 351-358.
21. Yu, X., Wu, L.C., Bowcock, A.M., Aronheim, A. and Baer, R. (1998) The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem., 273, 25388-25392.
22. Li, S., Ting, N.S., Zheng, L., Chen, P.L., Ziv, Y., Shiloh, Y., Lee, E.Y. and Lee, W.H. (2000) Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature, 406 210-215.
23. Wu, M., Soler, D.R., Abba, M.C., Nunez, M.I., Baer, R., Hatzis, C., Llombart-Cussac, A., Llombart-Bosch, A. and Aldaz, C.M. (2007) CtIP silencing as a novel mechanism of tamoxifen resistance in breast cancer. Mol. Cancer Res., 5, 1285-1295.
24. Provencher, D.M., Lounis, H., Champoux, L., Tetrault, M., Manderson, E.N., Wang, J.C., Eydoux, P., Savoie, R., Tonin, P.N. and Mes-Masson, A.M. (2000) Characterization of four novel epithelial ovarian cancer cell lines. In Vitro Cell. Dev. Biol. Anim., 36, 357-361.
25. Li, N.F., Broad, S., Lu, Y.J., Yang, J.S., Watson, R., Hagemann, T., Wilbanks, G., Jacobs, I., Balkwill, F., Dafou, D. et al. (2007) Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression. Cell Prolif., 40, 780-794.
26. Dafou, D., Ramus, S.J., Choi, K., Grun, B., Trott, D.A., Newbold, R.F., Jacobs, I.J., Jones, C. and Gayther, S.A. (2008) Chromosomes 6 and 18 induce neoplastic suppression in epithelial ovarian cancer cells. Int. J. Cancer, 124, 1037-1044.
27. Benjamini, Y. and Yekutieli, D. (2005) Quantitative trait Loci analysis using the false discovery rate. Genetics, 171, 783-790.
28. Song, H., Ramus, S.J., Quaye, L., DiCioccio, R.A., Tyrer, J., Lomas, E., Shadforth, D., Hogdall, E., Hogdall, C., McGuire, V. et al. (2006) Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis, 27, 2235-2242.
29. Zhao, Z.Z., Nyholt, D.R., Le, L., Martin, N.G., James, M.R., Treloar, S.A. and Montgomery, G.W. (2006) KRAS variation and risk of endometriosis. Mol. Hum. Reprod., 12, 671-676.
30. Khalique, L., Ayhan, A., Weale, M.E., Jacobs, I.J., Ramus, S.J. and Gayther, S.A. (2007) Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours. J. Pathol., 211, 286-295.